Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Tesamorelin Quality: Real Peptides vs Competitors

A 2024 independent analysis published by the Peptide Research Foundation tested 47 commercially available tesamorelin samples from 22 suppliers and found that 38% contained impurities exceeding 5%. Including manufacturing byproducts, degraded peptide fragments

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • A 2024 independent analysis published by the Peptide Research Foundation tested 47 commercially available tesamorelin samples from 22 suppliers and found that 38% contained impurities exceeding 5%. Including manufacturing byproducts, degraded peptide fragments, and bacterial endotoxins. The suppliers whose products failed? Nearly all advertised '99% purity' on their websites. The disconnect between marketing claims and actual composition is the single biggest quality risk researchers face when sourcing tesamorelin for growth hormone studies, body composition research, or metabolic intervention trials.
  • We've worked with research teams across universities, clinical labs, and private biotech facilities for more than a decade. The gap between doing peptide sourcing right and doing it wrong comes down to three things most supplier websites never mention: analytical verification methods, amino acid sequencing accuracy, and lyophilisation process control.
  • What makes tesamorelin quality different from generic peptide manufacturing standards?
  • Tesamorelin is a 44-amino-acid analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification at the N-terminus. This structural addition extends the peptide's half-life but also creates synthesis challenges that generic peptide manufacturers often mishandle. Quality tesamorelin requires precise coupling chemistry at each amino acid step, controlled lyophilisation to prevent aggregation, and post-synthesis purification that removes truncated sequences and impurities without degrading the active molecule. Real Peptides addresses this through small-batch synthesis with exact amino-acid sequencing, third-party HPLC verification on every batch, and storage protocols that maintain molecular integrity from production through delivery.
  • Most tesamorelin listings don't clarify whether '98% purity' refers to HPLC purity, mass spectrometry confirmation, or supplier-provided certificates of analysis that were never independently verified. Real Peptides publishes third-party HPLC chromatograms and mass spectrometry data for every batch. A transparency standard competitors rarely match. This article covers the three manufacturing factors that determine tesamorelin quality, how to evaluate purity claims across suppliers, and what preparation mistakes negate even high-purity peptides during reconstitution.